Product image of Pantogerolan (Pantoprazole) supplied by GNH India

Pantogerolan

Active Ingredient:
Pantoprazole
Origin:
EU

Pantogerolan (Pantoprazole)

Pantoprazole, the active ingredient in Pantogerolan, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is indicated for conditions such as gastro‑oesophageal reflux disease, erosive esophagitis, and peptic ulcer disease in adult patients.

GNH India supplies Pantogerolan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets.

Manufacturer / TM Owner

G.L. Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Pantoprazole is a proton pump inhibitor used to manage acid‑related gastrointestinal disorders.

  • Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief by decreasing gastric acid exposure to the esophagus.
  • Erosive esophagitis: promotes healing of damaged esophageal mucosa through acid suppression.
  • Peptic ulcer disease: facilitates ulcer healing and prevents recurrence by maintaining a low‑acid gastric environment.

How It Works

  • Pantoprazole selectively and irreversibly inhibits the H+/K+ ATPase enzyme (the gastric proton pump) located in the secretory canaliculi of parietal cells. By blocking this final step of acid secretion, it markedly reduces basal and stimulated gastric acid output, leading to an elevated gastric pH and allowing mucosal healing in acid‑related conditions.

Side Effects

Pantoprazole may be associated with a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

  • Headache: mild to moderate intensity.
  • Diarrhea: loose stools often transient.
  • Nausea: occasional feeling of queasiness.
  • Abdominal pain: mild discomfort in the stomach area.

Serious or Rare Side Effects

  • Acute interstitial nephritis: inflammation of kidney interstitium.
  • Severe allergic reactions: rash, angioedema, or anaphylaxis.
  • Clostridioides difficile infection: severe colitis risk.
  • Osteoporotic fractures: increased risk with long‑term use.

Precautions & Warnings

When prescribing Pantogerolan, clinicians should consider several precautionary measures to ensure safe use.

  • Assess renal function: dose adjustment may be needed in severe impairment.
  • Monitor for hypomagnesemia: prolonged therapy can lower serum magnesium.
  • Evaluate for osteoporosis risk: long‑term use may affect bone density.
  • Use with caution in hepatic impairment: limited data in severe liver disease.
  • Avoid abrupt discontinuation: may cause rebound acid hypersecretion.
  • Store at room temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Avoid Interactions

Pantogerolan can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Clopidogrel: reduced antiplatelet effect due to CYP2C19 inhibition.
  • Atazanavir or other protease inhibitors: decreased absorption leading to subtherapeutic levels.
  • Methotrexate: increased serum concentrations and toxicity risk.
  • Warfarin: potential enhancement of anticoagulant effect.

Moderate Interactions (Monitor Closely)

  • Digoxin: increased serum levels, monitor for toxicity.
  • Phenytoin: reduced plasma concentration, adjust dose if needed.
  • Iron supplements: decreased absorption of pantoprazole, separate administration times.

Frequently Asked Questions

Pantogerolan contains pantoprazole, a proton pump inhibitor indicated for the treatment of gastro‑oesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcer disease. It works by reducing stomach acid, helping to relieve symptoms and promote healing of the gastrointestinal lining.

Pantoprazole selectively and irreversibly blocks the H+/K+ ATPase enzyme, also known as the gastric proton pump, in the parietal cells of the stomach. This inhibition stops the final step of acid secretion, leading to a sustained increase in gastric pH and allowing damaged tissue to heal.

The appropriate dose of Pantogerolan is determined by the prescribing healthcare professional based on the patient’s condition, severity, and response to therapy. Dosage regimens may vary, and patients should follow the specific instructions provided by their prescriber.

Safety data for pantoprazole during pregnancy and lactation are limited. The drug should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Pregnant or nursing patients should discuss use with their healthcare provider.

To request Pantogerolan, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will verify trade or institutional credentials before providing pricing, availability, shipping details and any required import documentation.

Pantogerolan (pantoprazole) is comparable to other PPIs such as omeprazole or esomeprazole in its ability to suppress gastric acid. Differences may exist in pharmacokinetic profiles, drug‑interaction potential, and dosing convenience, but all share the same therapeutic goal of acid reduction for GERD and ulcer management.

Pantogerolan should be stored at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Pantogerolan is taken orally, usually as a whole tablet or capsule swallowed with a glass of water. It can be taken with or without food, but patients should follow the specific instructions given by their prescriber for optimal effectiveness.

Serious adverse events, though rare, include acute interstitial nephritis, severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, and increased risk of osteoporotic fractures with long‑term use. Patients should seek medical attention promptly if they experience any of these symptoms.

Pantogerolan should be avoided in patients with known hypersensitivity to pantoprazole or any component of the formulation. Caution is also advised for individuals with severe hepatic impairment, those taking medications that may interact significantly, and patients for whom acid suppression is contraindicated.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Pantoprazole

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT